Deficiencies and Inhibitors of Thromboplastic Activity

G. F Grannis; L. A Kazal

doi:10.1055/s-0038-1655646

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1966; 16(03/04): 574-585
DOI: 10.1055/s-0038-1655646

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Deficiencies and Inhibitors of Thromboplastic Activity

G. F Grannis^*

¹Cardeza Foundation for Hematological Research, Jefferson Medical College, Philadelphia, Pennsylvania

,

L. A Kazal

¹Cardeza Foundation for Hematological Research, Jefferson Medical College, Philadelphia, Pennsylvania

› Institutsangaben

Abstract

Summary

The effects of hereditary deficiencies of thromboplastic proteins (hemophilia A and B) on the time course of thrombin appearance and disappearance in plasma (the thrombin activity curve, TAC) were compared with the effects of a naturally occurring gamma-globulin inhibitor of thromboplastic activity and with an anti-thromboplastic activity derived from cephalin (phosphatidylserine-lipoprotein complex).

Both inhibitors inhibit reactions involving the protein in which hemophilia A plasma is deficient (factor VIII).

Volltext

Referenzen

References
1 Tocantins L. M. Cephalin, Protamine and the Antithromboplastic Activity of Normal and Hemophilic Plasmas. Proc. Soc. exp. Biol. (N. Y.) 54: 94 1943;
2 Tocantins L. M. Influence of the Contacting Surface on the Coagulability and Anticephalin Activity of Normal and Hemophilic Plasmas. Amer. J. Physiol 143: 67 1945;
3 Tocantins L. M. Hemophilic Syndromes and Hemophilia. Blood 9: 281 1954;
4 Kazal L. A, Miller O. P, Turner D. L, Tocantins L. M. Solubilization of Phosphatidyl Serine by Human Lipoprotein with Development of Anticephalin Anticoagulant activity. Fed. Proc 21: 59 1962;
5 Kazal L. A. Interactions of Phospholipids with Lipoproteins, with Serum and its Proteins, and with Proteolytic and Nonproteolytic Enzymes in Blood Clotting. Trans. N.Y. Acad. Sci 27: 613 1965;
6 Marcus A. J, Spaet T. H. Platelet Phosphatides: Their Separation, Identification and Clotting Activity. J. clin. Invest 37: 1836 1958;
7 Silver M. J, Turner D. L, Tocantins L. M. Phospholipid Antithromboplastin-Assay in vitro and Evaluation in vivo of Purified Fractions. Amer. J. Physiol 190: 8 1957;
8 Spaet T.H. Anticoagulants from Platelets. J. appi. Physiol 18: 325 1957;
9 Munro F. L, Munro M. P. Elektrophoretic Isolation of a Circulating Anticoagulant. J. clin. Invest 25: 814 1946;
10 Margolius J. A, Jackson D. P, Ratnoff O. D. Medicine. (Baltimore) 40: 145 1961;
11 Stefanini M, Dameshek W. The Hemorrhagic Disorders. Chap. 8. Grune and Stratton; New York: 1962
12 Leitner A, Bidwell E, Dike G. W. R. An Antihaemophilic Globulin (Factor VIII) Inhibitor: Purification, Characterization and Reaction Kinetics. Brit. J. Haemat 9: 245 1963;
13 Tocantins L. M, Holburn R. R, Carroll R. T. In: Blood Coagulation, Hemorrhage and Thrombosis. Tocantins L. M, and Kazal L. A. eds. 298. Grune and Stratton; New York: 1964
14 Kazal L. A, Amsel S, Miller O. P, Tocantins L. M. The Preparation and some Properties of Fibrinogen Precipitated From Human Plasma. Proc. Soc. exp. Biol. (N. Y.) 113: 989 1963;
15 Sober H. A, Petersen E. A. Fed. Proc 17: 1116 1958;
16 Kazal L. A. Tocantins In: Blood Coagulation, Hemorrhage and Thrombosis. Tocantins L. M, and Kazal L. A. eds. 353 Grune and Stratton; New York: 1964
17 Grannis G. F, Kazal L. A, Tocantins M. The Spectrophotometric Determination of Thrombin Activity in Plasma, Thrombos. Diathes. haemorrh. (Stuttg.) 13: 330 1965;
18 Kazal L. A, Grannis G. F, Tocantins L. M. The Reactions of Thrombin with Fibrinogen and Plasma Antithrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 343 1965;
19 Ferguson J. H. In: Blood Coagulation, Hemorrhage and Thrombosis. Tocantins L. M, and Kazal L. A. eds. 315 Grune and Stratton; New York: 1964
20 Biggs R. In: Biological Aspects of Occlusive Vascular Disease. Chalmers D. G, and Gresham G. A. eds. 261 Cambridge University Press; 1964
21 Grannis G. F, Kazal L. A. Prothrombin and Antithrombin: Their Opposing Functions in Blood Coagulation. Thrombos. Diathes. haemorrh. (Stutt.) 16: 497 1966;
22 Wright I. S. Nomenclature of Blood Clotting Factors. Thrombos. Diathes. haemorrh. (Stuttg.) 7: 381 1962;
23 Surgenor D. M, Steele B. B, Wallach D. F. H. Thrombin Formation in Purified Systems. Thrombos. Diathes. haemorrh. (Stuttg.) 3: 214 1959;
24 Macfarlane R.G. An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier. Nature (Lond.) 202: 498 1964;
25 Davie E. W, Ratnoff O. D. Waterfall Sequence for Intrinsic Blood Clotting. Science 145: 1310 1964;
26 Kazal L. A. Coagulation Proteins. In: The Serum Proteins and the Dysproteinemias. Sunderman F. W, and Sunderman Jr. F. W. eds. Chap. 29. Lippincott; Philadelphia: 1964
27 Seegers W. H. Basic Enzymology of Blood Coagulation. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 575 1965;
28 Ratnoff O. D. Estimation of Hageman Factor in Plasma or Plasma Fractions in Blood Coagulation, Hemorrhage and Thrombosis. Tocantins L. M, and Kazal L. A. eds. 141 Grune and Stratton; New York: 1964